Nikkei 225 & Eli Lilly and Company
6 shared events · Importance 4 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Nikkei 225: The Nikkei 225 index jumped, lifted by gains for tech-related shares and positive economic data from Japan, indicating a strong performance in the Japanese market.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 72 articles
Business
Nikkei 225: Fell over 5% in a single day, driven by losses in tech and AI-related stocks.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
International
Nikkei 225: Tokyo's Nikkei closed at a record high, contributing to the positive sentiment in Asian markets, partly driven by global optimism.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 18, 2026 · 309 articles
International
Nikkei 225: Tokyo's Nikkei closed at a record high, contributing to the positive sentiment in Asian markets, partly driven by global optimism.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Nikkei 225 and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard